Intercept Pharmaceuticals (ICPT-OLD)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 2,827 | 0.00 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 94.24% | 46,273 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 32.82% | 12,133 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 127.60% | 20,725 | 0.01 | |
| ≡ | David Einhorn - Greenlight Capital | Sell 100.00% | 81,856 | 0.12 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 16,242 | 0.01 | |
| ≡ | David Einhorn - Greenlight Capital | Reduce 18.14% | 18,144 | 0.03 | |
| Q3 2020 | |||||
| ≡ | David Einhorn - Greenlight Capital | Buy | 100,000 | 0.34 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.